Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion type Assertion NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_head.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_provenance.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion evidence source_evidence_literature NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_provenance.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion SIO_000772 21538969 NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_provenance.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion wasDerivedFrom befree-20150227 NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_provenance.
- NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_assertion wasGeneratedBy ECO_0000203 NP584944.RAPDis63vHLu0vgy4jwtGG5_ANmBBnHoy9wN4C6AkxPgE130_provenance.